Serious diseases like Alzheimer's often go undetected until symptoms appear—such as forgetfulness, reduced thinking ability, and difficulty with everyday tasks. However, scientists have now developed a predictive model that can predict the risk of these problems nearly 10 years before they begin. This discovery is significant because early intervention could help slow the disease's progression.

What is this new tool?
Researchers at the Mayo Clinic in the US have developed an advanced tool designed to simulate a predictive model. This tool combines several key factors to estimate a person's likelihood of developing mild cognitive impairment or dementia.

The model primarily included the following factors:

Age and gender

Genetic risk factors, such as the APOE e4 variant

Levels of amyloid protein in the brain are considered a primary marker of Alzheimer's

Information from PET scans

All these indicators are combined to create a risk level that indicates a person's likelihood of cognitive decline over 10 years or a lifetime.

Study based on data from 5,858 people
The study, published in The Lancet Neurology journal, analyzed long-term data from 5,858 participants. This data was taken from the ongoing Mayo Clinic Study of Aging project in Minnesota, USA, which has been researching the relationship between brain health and aging for decades.

People with the APOE e4 gene—whether men or women—were found to have a higher lifetime risk of Alzheimer's.

Women may be more susceptible than men to Alzheimer's or mild cognitive impairment throughout life.
The higher the amyloid level detected on a PET scan, the greater the risk of dementia or memory problems in the future.

How does it help?
PET scans can detect amyloid protein deposits in the brain. This is the same protein that reflects early changes associated with Alzheimer's. The new tool combines this information with other factors to create a clear risk profile.

This can predict:

Whether a person will develop mild cognitive impairment in the next 10 years

Or how likely they are to develop dementia in their lifetime

This tool helps both doctors and patients understand when to initiate interventions—such as medications, regular mental exercises, physical activity, or lifestyle changes.

A major step forward for doctors

According to the research team, this model could prove crucial in improving personalized care in the future. Just as cholesterol levels are used to predict heart attack risk, this tool will also help predict an individual's brain health.

Although this is currently a research-based tool, experts believe it could revolutionize the early detection of Alzheimer's.

While there is no definitive cure for Alzheimer's, early detection can significantly slow its progression. This new tool, developed by the Mayo Clinic, could make brain health monitoring more accurate and personalized in the future, helping people take timely action.

PC Social Media